Editorial
Published on 23 Nov 2023
Editorial: Advances in anti-malarial drug discovery
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1335842
- 866 views
Type at least 3 characters
128 articles
Articles
Original Research
Published on 22 Nov 2023
Targeting a cancer-specific LYPD3 glycoform for tumor therapy
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1298916
- 2,233 views
Review
Published on 21 Nov 2023
Future treatments for the arteriopathy of ectopic calcification disorders
in Cardiovascular and Hematologic Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1249966
- 1,454 views
Original Research
Published on 14 Nov 2023
In vitro drug interaction of ionophores with artemisinin and chloroquine against Plasmodium falciparum 3D7 blood-stage infection
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1257698
- 1,036 views
Original Research
Published on 30 Oct 2023
An improved method for large scale generation and high-throughput functional characterization of human iPSC-derived microglia
in Technologies and Strategies to Enable Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1289314
- 1,624 views
Review
Published on 18 Sep 2023
State-of-the-art strategies to prioritize Mycobacterium tuberculosis drug targets for drug discovery using a subtractive genomics approach
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1254656
- 1,614 views
- 1 citation
Mini Review
Published on 05 Sep 2023
Harnessing bioluminescence for drug discovery and epigenetic research
in Technologies and Strategies to Enable Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1249507
- 2,190 views
- 1 citation
Brief Research Report
Published on 03 Aug 2023
Novel mesothelin antibodies enable crystallography of the intact mesothelin ectodomain and engineering of potent, T cell-engaging bispecific therapeutics
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1216516
- 3,053 views
- 3 citations
Review
Published on 25 Jul 2023
The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1237655
- 1,743 views
- 3 citations
Original Research
Published on 20 Jul 2023
9-PAHSA displays a weak anti-inflammatory potential mediated by specific antagonism of chemokine G protein-coupled receptors
in Anti-inflammatory and Immunomodulating Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1138461
- 1,713 views
Review
Published on 13 Jul 2023
Targeting proteases and proteolytic processing of unusual N-terminal extensions of Plasmodium proteins: parasite peculiarity
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1223140
- 1,394 views
Mini Review
Published on 12 Jul 2023
FAIR data management: what does it mean for drug discovery?
in Technologies and Strategies to Enable Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1226727
- 1,943 views
- 3 citations
Original Research
Published on 07 Jul 2023
The tumor suppressor 5A2, a synthetic miR-7-5p mimic, targets oncogenic and metabolic pathways, as revealed by transcriptome-wide analysis
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1181637
- 1,067 views
Review
Published on 21 Jun 2023
Yin-yang in drug discovery: rethinking de novo design and development of predictive models
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1222655
- 3,952 views
- 3 citations
Original Research
Published on 15 Jun 2023
MMV006087 is a potent Malaria Box compound against Plasmodium falciparum clinical parasites
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1190471
- 1,457 views
Review
Published on 01 Jun 2023
Lessons that can be learned from the SARS-CoV-2 pandemic and their impact on the prophylaxis and treatment development for neglected tropical arboviruses
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1176768
- 2,820 views